Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Multimorbidity
- Sponsor
- University of Paris 5 - Rene Descartes
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- care pathway
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients
Detailed Description
The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date. This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment.
Investigators
Alexandre MALMARTEL
Academic doctor of medicine
University of Paris 5 - Rene Descartes
Eligibility Criteria
Inclusion Criteria
- •over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study
Exclusion Criteria
- •seen at home
- •unable to respond (cognitive problems or language barrier)
Outcomes
Primary Outcomes
care pathway
Time Frame: over the past 1 year
the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database
Continuity of care
Time Frame: over the past 1year
Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care)
Secondary Outcomes
- global quality of life(over the past 1 year)
- burden of traitement(over the past 1 year)